Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Urinary incontinence Medicare coverage

This article was originally published in The Gray Sheet

Executive Summary

Biofeedback, pelvic floor stimulation, sacral nerve stimulation and bulking agents will be discussed by the Medical and Surgical Procedures Panel of the Medicare Coverage Advisory Committee at its Jan. 19-20, 2000 meeting in Baltimore, MD, according to an Oct. 13 notice. The panel also will advise the Health Care Financing Administration on the "design of an overall diagnosis and treatment algorithm for urinary incontinence," including pelvic muscle rehabilitation, bulking agents, and behavioral, surgical, and pharmacologic therapies

Latest Headlines
See All
UsernamePublicRestriction

Register

MT012468

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel